{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:11:45Z","timestamp":1775265105501,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/pr.2016.53","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T17:29:58Z","timestamp":1458581398000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genotype-guided antiretroviral regimens in children with multidrug-resistant HIV-1 infection"],"prefix":"10.1038","volume":"80","author":[{"given":"Gloria","family":"Huerta-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 G.","family":"Vazquez-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Mata-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leoncio","family":"Peregrino-Bejarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Flores-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortino","family":"Sol\u00f3rzano-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"BFpr201653_CR1","doi-asserted-by":"publisher","first-page":"18555","DOI":"10.7448\/IAS.16.1.18555","volume":"16","author":"AH Sohn","year":"2013","unstructured":"Sohn AH, Hazra R. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc 2013;16:18555.","journal-title":"J Int AIDS Soc"},{"key":"BFpr201653_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/apc.2008.0153","volume":"23","author":"C Foster","year":"2009","unstructured":"Foster C, Judd A, Tookey P, et al.; Collaborative HIV Paediatric Study (CHIPS). Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS 2009;23:159\u201366.","journal-title":"AIDS Patient Care STDS"},{"key":"BFpr201653_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2334-7-55","volume":"7","author":"B Larru","year":"2007","unstructured":"Larru B, de Mendoza C, Bell\u00f3n JM, et al. Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children. BMC Infect Dis 2007;7:55.","journal-title":"BMC Infect Dis"},{"key":"BFpr201653_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/archdischild-2014-307019","volume":"100","author":"K Le Doare","year":"2015","unstructured":"Le Doare K, Mackie NE, Kaye S, Bamford A, Walters S, Foster C. Virtual support for paediatric HIV treatment decision making. Arch Dis Child 2015;100:527\u201331.","journal-title":"Arch Dis Child"},{"key":"BFpr201653_CR5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1056\/NEJM199705083361901","volume":"336","author":"WT Shearer","year":"1997","unstructured":"Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997;336:1337\u201342.","journal-title":"N Engl J Med"},{"key":"BFpr201653_CR6","unstructured":"Panel on Antiretroviral Therapy and Medical Management of HIV-1 Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection, 2013. ( http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/pediatricguidelines.pdf .)"},{"key":"BFpr201653_CR7","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1542\/peds.109.4.e61","volume":"109","author":"RB Van Dyke","year":"2002","unstructured":"Van Dyke RB, Lee S, Johnson GM, et al.; Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002;109:e61.","journal-title":"Pediatrics"},{"key":"BFpr201653_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/QAD.0b013e328330abaa","volume":"23","author":"S Blanche","year":"2009","unstructured":"Blanche S, Bologna R, Cahn P, et al. Pharmacokinetics, safety and efficacy of darunavir\/ritonavir in treatment-experienced children and adolescents. AIDS 2009;23:2005\u201313.","journal-title":"AIDS"},{"key":"BFpr201653_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2147\/TCRM.S4595","volume":"5","author":"M Neely","year":"2009","unstructured":"Neely M, Kovacs A. Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir. Ther Clin Risk Manag 2009;5:595\u2013615.","journal-title":"Ther Clin Risk Manag"},{"key":"BFpr201653_CR10","first-page":"642","volume":"22","author":"AM Wensing","year":"2014","unstructured":"Wensing AM, Calvez V, G\u00fcnthard HF, et al. 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med 2014;22:642\u201350.","journal-title":"Top Antivir Med"},{"key":"BFpr201653_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1545109712463073","volume":"12","author":"BL Kirk","year":"2013","unstructured":"Kirk BL, Gomila A, Matshaba M, et al. Early outcomes of darunavir- and\/or raltegravir-based antiretroviral therapy in children with multidrug-resistant HIV at a pediatric center in Botswana. J Int Assoc Provid AIDS Care 2013;12:90\u20134.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"BFpr201653_CR12","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/QAD.0b013e328331a456","volume":"23","author":"I Thuret","year":"2009","unstructured":"Thuret I, Chaix ML, Tamalet C, et al. Raltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. AIDS 2009;23:2364\u20136.","journal-title":"AIDS"},{"key":"BFpr201653_CR13","doi-asserted-by":"publisher","first-page":"605.e1","DOI":"10.1016\/j.cmi.2015.02.003","volume":"21","author":"P Rojas S\u00e1nchez","year":"2015","unstructured":"Rojas S\u00e1nchez P, de Mulder M, Fernandez-Cooke E, et al.; Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Paediatric Branch of the Spanish National AIDS Network (CoRISPe). Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses. Clin Microbiol Infect 2015;21:605.e1\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"BFpr201653_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/hiv.12141","volume":"15","author":"G Tudor-Williams","year":"2014","unstructured":"Tudor-Williams G, Cahn P, Chokephaibulkit K, et al.; PIANO study group. Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Med 2014;15:513\u201324.","journal-title":"HIV Med"},{"key":"BFpr201653_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/INF.0b013e31824580e8","volume":"31","author":"V Briz","year":"2012","unstructured":"Briz V, Le\u00f3n-Leal JA, Palladino C, et al. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents. Pediatr Infect Dis J 2012;31:273\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr201653_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","volume":"22","author":"EG Leonard","year":"2003","unstructured":"Leonard EG, McComsey GA. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J 2003;22:77\u201384.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr201653_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/QCO.0b013e3283298f1f","volume":"22","author":"RK Gupta","year":"2009","unstructured":"Gupta RK, Gibb DM, Pillay D. Management of paediatric HIV-1 resistance. Curr Opin Infect Dis 2009;22:256\u201363.","journal-title":"Curr Opin Infect Dis"},{"key":"BFpr201653_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/515596","volume":"178","author":"EJ Abrams","year":"1998","unstructured":"Abrams EJ, Weedon J, Steketee RW, et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis 1998;178:101\u20138.","journal-title":"J Infect Dis"},{"key":"BFpr201653_CR19","unstructured":"Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 23 February 2009, 2009. ( http:\/\/aidsinfo.nih.gov\/ContentFiles\/PediatricGuidelines.pdf .)"},{"key":"BFpr201653_CR20","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","volume":"353","author":"J Durant","year":"1999","unstructured":"Durant J, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet 1999;353:2195\u20139.","journal-title":"Lancet"},{"key":"BFpr201653_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/135965350000500102","volume":"5","author":"P Clevenbergh","year":"2000","unstructured":"Clevenbergh P, Durant J, Halfon P, et al. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther 2000;5:65\u201370.","journal-title":"Antivir Ther"},{"key":"BFpr201653_CR22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/135965350601100711","volume":"11","author":"H Green","year":"2006","unstructured":"Green H, Gibb DM, Compagnucci A, et al.; Paediatric European Network for the Treatment of AIDS. A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial. Antivir Ther 2006;11:857\u201367.","journal-title":"Antivir Ther"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201653","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:01Z","timestamp":1684616521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFpr201653"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.53","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]},"assertion":[{"value":"12 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}